Andrew A. Krakauer, CEO at CANTEL MEDICAL CORP (CMN), sold 19,140 shares at $42.59 ($815K) on 2014-12-29, disclosed to the SEC on 2014-12-29.
Open-market sale of $815k CMN by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TFX | BUY | 2018-08-08 | $238K | — | Filing → |
| CMN | SELL | 2015-12-31 | $590K | — | Filing → |
| CMN | SELL | 2015-10-14 | $1.2M | — | Filing → |